Some bioinformatics analyses have proved that ANKZF1 based genes signature can predict the prognosis of patients with colon cancer, renal cell carcinoma, and prostate cancer (14, 29–33). The gene discussed is ANKZF1; the disease is malignant colon neoplasm.